首页 关于我们
AlyerMax,Inc

ALYERMAX是一家医用大麻制造商,致力于生产CBD天然植物药。
ALYERMAX成立于加州奥克兰市,是一家总部位于奥克兰的股份有限公司。

ALYERMAX成为天然植物药行业和医疗配方实验室大麻医疗产品的领先生产商。
由熟练的管理团队执行的深思熟虑的商业计划

目标

成为金融投资组合和药用大麻的领导者
为我们的团队和药用大麻研发领域的投资者带来高收益和高回报

通过与我们的投资者、药用大麻行业的先驱、供应链和第三方买家等合作

我们将建立一个“人人共赢”的多利益体系。
完成市场份额,在3年内开发出连接国际销售渠道的产品。

使命

确保我们的投资者在药用大麻领域获得实质性收益

通过我们的投资、技术、供应链和工作状态最大限度地提高我们大麻药品的效益

通过与行业领先的公司建立伙伴关系和合资企业扩大行业市场份额

征求建议书
让我们成为您成功故事的一部分。 您对潜在项目有疑问吗?或者您想了解更多有关我们的服务?请通过联系表联系 AlyerMax团队的成员,我们的一位专家将尽快与您联系。我们期待与您合作!
管理团队
Albert z.Ye
Presidnt CEO
John Lin
Vice President
Dr. Sherry Zhang
哈佛大學醫學與生物學博士後
世界500強 賽默飛科學家
C Colin Yang
CTO|首席技術官
Albert z.Ye
Presidnt CEO

Founder and CEO of Alyer Bioceuticals inc. Alyer distribution inc. Alyer Lab. Also establish a Alyer perfernent inc . In Nevada STATE. Also cooperated with New york state ,.President and founder American united energy inc and UMS investment inc ,both company is very succeed to develop the newKnowledge, spend10 year
7 year playboy International enterprise Inc for playboy Event
Operate Asian desk in Capital office with RGA in DC. years
Engineering of structure of city planning DCL INC., SF, CA years

John Lin
Vice President

He has more than 17 years life science lab research in Pharmacological and Molecular Biological experience published more 20 papers with 20 year+ technology transfer, a biotech start-up, commercialization and joint venture for the global business development

Dr. Sherry Zhang
哈佛大學醫學與生物學博士後
世界500強 賽默飛科學家

Dr. Sherry Zhang: Doctor of Medicine and Biology, postdoctoral fellow at Harvard University. He has studied in Europe and America for more than 20 years, and is engaged in the research of tumor gene and molecular biology and the research and development of anti-tumor antibody drugs.
He is currently working as a scientist in Thermo Fisher Scientific, a Fortune 500 biological company. He has published many academic papers in famous academic journals at home and abroad, and won many academic awards.
At the same time, Dr. Zhang has been serving as a senior medical consultant in Weikang Pharmaceuticals for more than ten years. It has played a huge role in the development and growth of Weikang Pharmaceuticals.

C Colin Yang
CTO|首席技術官

Results-focused scientific leader with 20+ years industry experience. Areas of expertise include immunology, monoclonal antibody production, characterization, molecular biology, protein biochemistry, and assay development. Quality-driven and highly organized, with exceptional presentation and writing skills. Excellent bench skills and expertise in a wide range of technologies. Enthusiastic, self-motivated and quality-driven, eager to meet challenges and quickly assimilate knowledge and technologies in new areas. Strong team leader with the proven collaborative nature and managerial ability to lead productive multidisciplinary teams.